期刊文献+

流行性感冒患儿继发细菌性肺炎的危险因素分析与临床预测模型构建

Analysis of risk factors for secondary bacterial pneumonia in children with influenza and construction of clinical prediction model
暂未订购
导出
摘要 目的探究儿童流感后出现细菌性肺炎的独立危险因素,建立临床预测模型,以便早期识别出高危儿童。方法回顾性选择2023年1月-2024年5月重庆市高新区人民医院儿科收治的315例流感住院患儿,根据是否继发细菌性肺炎分为肺炎组(105例)和非肺炎组(210例)。收集患儿临床资料,用单因素、多因素Logistic回归分析筛选独立危险因素,并建立列线图预测模型。用Bootstrap法做内部验证,用ROC曲线来评价模型的区分度。结果年龄小于3岁、抗病毒治疗时间超过48小时、有基础疾病、高热(39℃以上)和炎症指标(中性粒细胞比例、CRP、PCT)升高与继发肺炎有关(P<0.05)。经过多因素分析得到年龄≤3岁(OR=2.85,95%CI:1.62-5.01)、延迟抗病毒治疗(OR=3.42,95%CI:1.98-5.91)、有基础病(OR=2.51,95%CI:1.38-4.55)、CRP≥40mg/L(OR=4.18,95%CI:2.38-7.33)是独立危险因素。由此建立的预测模型AUC值为0.846,95%可信区间为0.802-0.890,内部验证证明模型有良好的校准度。结论年龄小、延迟抗病毒治疗、有基础疾病和高CRP水平为流感患儿继发细菌性肺炎的独立危险因素。建立的临床预测模型有较好的预测效能,可早期发现高危患儿,指导临床干预。 Objective To explore the independent risk factors for bacterial pneumonia in children after influenza and establish a clinical prediction model in order to identify high-risk children at an early stage.Methods A retrospective selection was made of 315 hospitalized children with influenza admitted to the Pediatrics Department of Chongqing High-tech Zone People’s Hospital from January 2023 to May 2024.They were divided into the pneumonia group(105 cases)and the non-pneumonia group(210 cases)based on whether secondary bacterial pneumonia occurred.Clinical data of the children patients were collected.Independent risk factors were screened by univariate and multivariate Logistic regression analyses,and a nomogram prediction model was established.Internal validation was conducted using the Bootstrap method,and the ROC curve was used to evaluate the discrimination of the model.Results Age less than 3 years old,antiviral treatment duration exceeding 48 hours,underlying diseases,high fever(above 39℃),and elevated inflammatory indicators(neutrophil ratio,CRP,PCT)were associated with secondary pneumonia(P<0.05).Through multivariate analysis,it was found that the age was≤3 years old(OR=2.85,95%CI:1.62-5.01),delayed antiviral treatment(OR=3.42,95%CI:1.98-5.91),and had underlying diseases(OR=2.51,95%CI:1.38-4.55),CRP≥40mg/L(OR=4.18,95%CI:2.38-7.33)was an independent risk factor.The AUC value of the prediction model established thereby is 0.846,and the 95%confidence interval is from 0.802 to 0.890.Internal validation proves that the model has good calibration.Conclusion Young age,delayed antiviral treatment,underlying diseases and high CRP levels are independent risk factors for secondary bacterial pneumonia in children with influenza.The established clinical prediction model has good predictive efficacy,can detect high-risk children at an early stage,and guide clinical intervention.
作者 费勇 夏爽 Fei Yong;Xia Shuang(Chongqing High-tech Zone People’s Hospital,Chongqing 400050,China;Jiulongpo District Erlang Sub-district Community Health Service Center,Chongqing 400038,China)
出处 《首都食品与医药》 2026年第4期52-54,共3页 Capital Food Medicine
关键词 流行性感冒 儿童 细菌性肺炎 危险因素 预测模型 Influenza Children Bacterial pneumonia Risk factors Predictive model
  • 相关文献

参考文献9

二级参考文献95

  • 1钱蔓华.奥司他韦联合小儿豉翘清热颗粒治疗儿童流行性感冒的疗效观察[J].名医,2020(11):296-297. 被引量:5
  • 2刘妮,徐志.扎那米韦的合成及临床应用进展[J].国外医药(抗生素分册),2020(5):347-353. 被引量:3
  • 3Sun YM, Hoang T, Neubauer JA, et al. Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson'S disease [ J ]. J Neural Sei, 2011,304 ( 1 - 2 ) : 93 - 101.
  • 4Park IH, Lee SH, Yu ST,et al. Serum procalcitoniu as a diagnostic marker of neonatal sepsis[J]. Korean J Pediatr,2014 ,57(10) :451 - 456.
  • 5Tschaikowsky K, Hedwig GM, Schiele A, et al. Coincidence of pro - and anti - inflammcaory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen - DR expression, procalcitonin, C - reactive protein, and changes in T -cell subsets in septic and postopercetive patients [ J ]. Crit Care Med,2002,30(5) :1015 - 1023.
  • 6Casaclo FJ, Blanco QA. Procalcitonin. A new marker for bacterial in- fection [ J ]. An Esp Pediatr, 2001,54 ( 1 ) :69 - 73.
  • 7Reinhart K, Meisner M. Biomarkers in the critically ill patient: pro- calcitonin [J]. Crit Care Clin, 2011,27(2) :253 -263.
  • 8Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to re- duce patients'exposure to antibiotics in intensive care units(PRORA- TA trial) : amuhieentre randomised controlledtrial [ J ]. Lancet, 2010,375 (9713) :463 - 474.
  • 9Arora S, Singh P, Singh PM, et al. Procalcitonin levels in survivors and nun survivors mr sepsis: systematic review and Meta - analysis [J]. Shock,2015,43(3) :212 -221.
  • 10Lee M, Snyder A. The role of procalcitonin in community - acquied pneumonia: a literature review [ J]. Adv Emerg Nurs J,2012,34 (3) :259 -271.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部